MorphoSys AG (MOR.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
As of 08:02AM CEST. Market open.
| Previous close | 70.15 |
| Open | 70.00 |
| Bid | 70.00 x 0 |
| Ask | 70.10 x 0 |
| Day's range | 70.00 - 70.00 |
| 52-week range | 15.43 - 70.00 |
| Volume | |
| Avg. volume | 60 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 07 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.MorphoSys (ETR:MOR) shareholders have earned a 228% return over the last year
When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right...
Business WireMorphoSys AG Reports First Quarter 2024 Financial Results
PLANEGG/MUNICH, Germany, April 29, 2024--MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2024.
ZacksNovartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.
© 2024 Yahoo. All rights reserved.